NCT01712854View on ClinicalTrials.gov

Effects of Symbicort on the Ventilatory Kinematics

PHASE4TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Chronic Obstructive Lung Disease
Interventions
DRUG

Budesonide

budesonide 80 mcg

DRUG

Symbicort

A combination of budesonide and long acting beta agonist: Budesonide 80 mcg and formoterol fumarate dihydrate inhaler 4.5 mcg

Trial Locations (1)

10032

Columbia University Medical Center, New York

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Columbia University

OTHER